The development of a new cancer treatment will require "time and
cunning", but could be effective eventually, a scientist has
suggested. Dr Paul Edwards, from the University of Cambridge,
recently identified a gene - called Neurogulin-1 - which is
damaged in more than half of the cases of breast cancer and
could lead to progress in the treatment of the illness. He said
that this discovery is important because knowing how a cell
becomes cancerous may provide the key to developing effective
treatment, which is why Neurogulin-1 could be so important. Dr
Edwards explained: "It isn't easy to put something back that's
broken, so it will take time and cunning to develop new
treatments based on this discovery. But it might be possible in
time." Research by Breast Cancer Care indicates that a person is
diagnosed with the illness every 11 minutes in the UK, with
around 46,000 new cases reported each year.